Methods of treatment and screening assays for hif-1alpha regulation
AssigneeUniversity of Rochester
InventorMarc Halterman
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Rochester
InventorMarc Halterman
Estimating the term…
The present invention relates to a method of treating a patient for a condition where blood flow to a tissue or organ is interrupted. This method involves administering to a patient with a hypoxic condition where blood flow to a tissue or organ is interrupted, or at risk thereof, a compound that reduces the rate of HIF-1α inactivation in cells affected by the condition, thereby treating the patient for the condition. Also disclosed is a method of treating a tumor in a patient. In addition, the present invention relates to methods of identifying compounds as candidate drugs for treatment of hypoxic conditions and for treating tumors in a subject.
A method of treating a patient for a condition where blood flow to a tissue or organ is interrupted, said method comprising:
A method of treating a tumor in a patient, said method comprising administering to the patient a compound capable of disrupting activity of HIF-1α in tumor cells.
A method of identifying compounds as candidate drugs for treatment of hypoxic conditions, said method comprising:
A method of identifying compounds as candidate drugs for treating tumors in a subject, said method comprising:
Dependencies are inferred from the claim text.